SEC Form 4 · accession 0001209191-15-051055
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yoav Sibony
Officer — VP - Global Sales
Period of report
Jun 4, 2015
Accepted (ET)
Jun 8, 2015 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 4, 2015 | A | 10,335 | $0.00 | A | 10,335 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2 | $5.56 | Jun 4, 2015 | A | 19,500 | A | — | Jun 4, 2025 | Common Stock, par value $0.01 per share | 19,500 | 19,500 | D |
Explanation of responses
- F1Represents a deferred stock award of 10,335 restricted stock units which shall vest in four equal installments on January 1, 2016, 2017, 2018 and 2019.
- F2The options vest in four equal installments on January 1, 2016, 2017, 2018 and 2019.
Remarks
This form is signed under power of attorney.